RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Using Pre-Clinical Studies to Explore the Potential Clinical Uses of Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem cells

      한글로보기

      https://www.riss.kr/link?id=A108769944

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Recent studies of exosomes derived from mesenchymal stem cells (MSCs) have indicated high potential clinical applications in many diseases. However, the limited source of MSCs impedes their clinical research and application. Most recently, induced pluripotent stem cells (iPSCs) have become a promising source of MSCs. Exosome therapy based on iPSC-derived MSCs (iMSCs) is a novel technique with much of its therapeutic potential untapped. Compared to MSCs, iMSCs have proved superior in cell proliferation, immunomodulation, generation of exosomes capable of controlling the microenvironment, and bioactive paracrine factor secretion, while also theoretically eliminating the dependence on immunosuppression drugs. The therapeutic effects of iMSC-derived exosomes are explored in many diseases and are best studied in wound healing, cardiovascular disease, and musculoskeletal pathology. It is pertinent clinicians have a strong understanding of stem cell therapy and the latest advances that will eventually translate into clinical practice. In this review, we discuss the various applications of exosomes derived from iMSCs in clinical medicine.
      번역하기

      Recent studies of exosomes derived from mesenchymal stem cells (MSCs) have indicated high potential clinical applications in many diseases. However, the limited source of MSCs impedes their clinical research and application. Most recently, induced plu...

      Recent studies of exosomes derived from mesenchymal stem cells (MSCs) have indicated high potential clinical applications in many diseases. However, the limited source of MSCs impedes their clinical research and application. Most recently, induced pluripotent stem cells (iPSCs) have become a promising source of MSCs. Exosome therapy based on iPSC-derived MSCs (iMSCs) is a novel technique with much of its therapeutic potential untapped. Compared to MSCs, iMSCs have proved superior in cell proliferation, immunomodulation, generation of exosomes capable of controlling the microenvironment, and bioactive paracrine factor secretion, while also theoretically eliminating the dependence on immunosuppression drugs. The therapeutic effects of iMSC-derived exosomes are explored in many diseases and are best studied in wound healing, cardiovascular disease, and musculoskeletal pathology. It is pertinent clinicians have a strong understanding of stem cell therapy and the latest advances that will eventually translate into clinical practice. In this review, we discuss the various applications of exosomes derived from iMSCs in clinical medicine.

      더보기

      참고문헌 (Reference)

      1 Sidhom K, "is size exclusion chromatography the best option?" 21 : 6466-, 2020

      2 Lazennec G, "adult multipotent stromal cells and cancer : risk or benefit?" 26 : 1387-1394, 2008

      3 Kujath P, "Wounds–from physiology to wound dressing" 105 : 239-248, 2008

      4 Troyer DL, "Wharton’s jelly-derived cells are a primitive stromal cell population" 26 : 591-599, 2008

      5 O’Brien J, "Visual hallucinations in neurological and ophthalmological disease : pathophysiology and management" 91 : 512-519, 2020

      6 Balcer LJ, "Vision and vision-related outcome measures in multiple sclerosis" 138 : 11-27, 2015

      7 "U.S. National Library of Medicine"

      8 Le Blanc K, "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells" 363 : 1439-1441, 2004

      9 Orozco L, "Treatment of knee osteoarthritis with autologous mesenchymal stem cells : a pilot study" 95 : 1535-1541, 2013

      10 Monguio´-Tortajada M, "Tolerance in organ transplantation : from conventional immunosuppression to extracellular vesicles" 5 : 416-, 2014

      1 Sidhom K, "is size exclusion chromatography the best option?" 21 : 6466-, 2020

      2 Lazennec G, "adult multipotent stromal cells and cancer : risk or benefit?" 26 : 1387-1394, 2008

      3 Kujath P, "Wounds–from physiology to wound dressing" 105 : 239-248, 2008

      4 Troyer DL, "Wharton’s jelly-derived cells are a primitive stromal cell population" 26 : 591-599, 2008

      5 O’Brien J, "Visual hallucinations in neurological and ophthalmological disease : pathophysiology and management" 91 : 512-519, 2020

      6 Balcer LJ, "Vision and vision-related outcome measures in multiple sclerosis" 138 : 11-27, 2015

      7 "U.S. National Library of Medicine"

      8 Le Blanc K, "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells" 363 : 1439-1441, 2004

      9 Orozco L, "Treatment of knee osteoarthritis with autologous mesenchymal stem cells : a pilot study" 95 : 1535-1541, 2013

      10 Monguio´-Tortajada M, "Tolerance in organ transplantation : from conventional immunosuppression to extracellular vesicles" 5 : 416-, 2014

      11 Zheng Q, "The unique immunomodulatory properties of MSC-derived exosomes in organ transplantation" 12 : 659621-, 2021

      12 Gao J, "The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion" 169 : 12-20, 2001

      13 Kalluri R, "The biology, function, and biomedical applications of exosomes" 367 : eaau6977-, 2020

      14 Lei L, "Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis" 34 (34): 14-22, 2016

      15 Mandelkow EM, "Tau in alzheimer’s disease" 8 : 425-427, 1998

      16 Hosseini SA, "Stem cell-and gene-based therapies as potential candidates in alzheimer’s therapy" 119 : 8723-8736, 2018

      17 Justiz Vaillant AA, "StatPearls" StatPearls Publishing 2022

      18 Herberts CA, "Risk factors in the development of stem cell therapy" 9 : 29-, 2011

      19 Lai RC, "Proteolytic potential of the MSC exosome proteome : implications for an exosome-mediated delivery of therapeutic proteasome" 2012 : 971907-, 2012

      20 Bloor AJC, "Production, safety and efficacy of ipsc-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease : a phase I, multicenter, open-label, dose-escalation study" 26 : 1720-1725, 2020

      21 Chang MG, "Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model" 113 : 1832-1841, 2006

      22 Breitbach M, "Potential risks of bone marrow cell transplantation into infarcted hearts" 110 : 1362-1369, 2007

      23 Wilson SE, "Pathophysiology of corneal scarring in persistent epithelial defects after PRK and other corneal injuries" 34 : 59-64, 2018

      24 Liu L, "PSC-MSCderived exosomes protect against kidney fibrosis in vivo and in vitro through the SIRT6/b-Catenin signaling pathway" 14 : 310-319, 2010

      25 Sharma GD, "P38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing : evidence of cross-talk activation between MAP kinase cascades" 278 : 21989-21997, 2003

      26 Ozeki N, "Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats" 24 : 1061-1070, 2016

      27 Winston CN, "Neuronal exosome-derived human tau is toxic to recipient mouse neurons in vivo" 67 : 541-553, 2019

      28 Iqbal K, "Neurofibrillary pathology leads to synaptic loss and not the other way around in alzheimer disease" 4 : 235-238, 2002

      29 Katsuda T, "Molecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repair" 6 : 212-, 2015

      30 Zemljic M, "Modern stem cell therapy : approach to disease" 127 : S199-S203, 2015

      31 Jiang Y, "Micro-RNA-137 inhibits tau hyperphosphorylation in alzheimer’s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells" 24 : 5635-5644, 2018

      32 English K, "Mesenchymal stromal cells:facilitators of successful transplantation?" 7 : 431-442, 2010

      33 Zhang B, "Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway" 20 : 687-696, 2018

      34 Hynes K, "Mesenchymal stem cells from IPS cells facilitate periodontal regeneration" 92 : 833-839, 2013

      35 Devine SM, "Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates" 101 : 2999-3001, 2003

      36 Wang B, "Mesenchymal stem cells deliver exogenous MicroRNALet7c via exosomes to attenuate renal fibrosis" 24 : 1290-1301, 2016

      37 Arslan F, "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury" 10 : 301-312, 2013

      38 Ankrum J, "Mesenchymal stem cell therapy : two steps forward, one step back" 16 : 203-209, 2010

      39 Shabbir A, "Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro" 24 : 1635-1647, 2015

      40 Liu W, "Mesenchymal stem cell exosome-derived MiR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells" 12 : 153-, 2021

      41 Sabel BA, "Mental stress as consequence and cause of vision loss : the dawn of psychosomatic ophthalmology for preventive and personalized medicine" 9 : 133-160, 2018

      42 Katzman LR, "Management strategies for persistent epithelial defects of the cornea" 28 : 168-172, 2014

      43 Bailey AJM, "MSC-derived extracellular vesicles to heal diabetic wounds : a systematic review and meta-analysis of preclinical animal studies" 18 : 968-979, 2022

      44 Luo T, "MSC-derived extracellular vesicles in tumors and therapy" 13 : 5212-, 2021

      45 Kordelas L, "MSC-derived exosomes : a novel tool to treat therapy-refractory graft-versus-host disease" 28 : 970-973, 2014

      46 Bataller R, "Liver fibrosis" 115 : 209-218, 2005

      47 Deng H, "Lipid, protein, and MicroRNA composition within mesenchymal stem cell-derived exosomes" 20 : 178-186, 2018

      48 Konoshenko MY, "Isolation of extracellular vesicles : general methodologies and latest trends" 2018 : e8545347-, 2018

      49 Horwitz EM, "Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta : implications for cell therapy of bone" 99 : 8932-8937, 2002

      50 Feng Y, "Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting mecp2 via MiR-22" 9 : e88685-, 2014

      51 Mak J, "Intra-articular injection of synovial mesenchymal stem cells improves cartilage repair in a mouse injury model" 6 : 23076-, 2016

      52 Wynn TA, "Integrating mechanisms of pulmonary fibrosis" 208 : 1339-1350, 2011

      53 Zhang H, "Inhibition of myocardial ischemia/reperfusion injury by exosomes secreted from mesenchymal stem cells" 2016 : 4328362-, 2016

      54 Hirschi KK, "Induced pluripotent stem cells for regenerative medicine" 16 : 277-294, 2014

      55 Xu M, "Induced pluripotent stem cell-derived mesenchymal stromal cells are functionally and genetically different from bone marrow-derived mesenchymal stromal cells" 37 : 754-765, 2019

      56 Yu J, "Induced pluripotent stem cell lines derived from human somatic cells" 318 : 1917-1920, 2007

      57 Kang L, "IPS cells can support full-term development of tetraploid blastocyst-complemented embryos" 5 : 135-138, 2009

      58 Zhang L, "Human pluripotent stem cell–mesenchymal stem cell-derived exosomes promote ovarian granulosa cell proliferation and attenuate cell apoptosis induced by cyclophosphamide in a poi-like mouse model" 28 : 2112-, 2023

      59 Ullah I, "Human mesenchymal stem cellscurrent trends and future prospective" 35 : e00191-, 2015

      60 Giuliani M, "Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-Cell cytolytic machinery" 118 : 3254-3262, 2011

      61 Rong X, "Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/b-catenin pathway" 10 : 98-, 2019

      62 Torres Crigna A, "Human adipose tissue-derived stromal cells suppress human, but not murine lymphocyte proliferation, via indoleamine 2, 3-dioxygenase activity" 9 : 2419-, 2020

      63 Sabapathy V, "HiPSC-derived IMSCs : NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine" 20 : 1571-1588, 2016

      64 Nong K, "Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats" 18 : 1548-1559, 2016

      65 Fujii S, "Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations" 36 : 434-445, 2018

      66 Bian S, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model" 92 : 387-397, 2014

      67 Raposo G, "Extracellular vesicles : exosomes, microvesicles, and friends" 200 : 373-383, 2013

      68 Tang Q, "Exosomesloaded thermosensitive hydrogels for corneal epithelium and stroma regeneration" 280 : 121320-, 2022

      69 Zhang J, "Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway" 7 : 136-, 2016

      70 Wang Y, "Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective MiRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium" 192 : 61-69, 2015

      71 Sugaya K, "Exosomes, stem cells and microRNA: aging, cancer and age related disorders" Springer International Publishing 61-84, 2018

      72 Kim S, "Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation" 19 : 3119-, 2018

      73 Liu X, "Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis" 13 : 232-244, 2017

      74 Qi X, "Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats" 12 : 836-849, 2016

      75 Hu G, "Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice" 6 : 10-, 2015

      76 Gao L, "Exosomes secreted by HiPSC-derived cardiac cells improve recovery from myocardial infarction in swine" 12 : eaay1318-, 2020

      77 Zhang J, "Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis" 13 : 49-, 2015

      78 Li KL, "Exosomes released from human bone marrow-derived mesenchymal stem cell attenuate acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in mice" 9 : 617589-, 2021

      79 Sharma P, "Exosomes regulate neurogenesis and circuit assembly" 116 : 16086-16094, 2019

      80 Ding M, "Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in alzheimer’s disease" 43 : 2165-2177, 2018

      81 Santoso MR, "Exosomes from induced pluripotent stem cell-derived cardiomyocytes promote autophagy for myocardial repair" 9 : e014345-, 2020

      82 Du Y, "Exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells(HiPSC-MSCs)protect liver against hepatic ischemia/ reperfusion injury via activating sphingosine kinase and sphingosine-1-phosphate signaling pathway" 43 : 611-625, 2017

      83 Chen M, "Exosomes from human induced pluripotent stem cells derived mesenchymal stem cells improved myocardial injury caused by severe acute pancreatitis through activating AKT/nrf2/HO-1 axis" 21 : 1578-1589, 2022

      84 Cui X, "Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through Wnt/b-Catenin signaling pathway" 70 : 225-231, 2017

      85 Bakhtyar N, "Exosomes from acellular wharton’s jelly of the human umbilical cord promotes skin wound healing" 9 : 193-, 2018

      86 Chen HX, "Exosomes derived from mesenchymal stem cells repair a parkinson’s disease model by inducing autophagy" 11 : 288-, 2020

      87 Xue C, "Exosomes derived from hypoxia-treated human adipose mesenchymal stem cells enhance angiogenesis through the PKA signaling pathway" 27 : 456-465, 2018

      88 Li T, "Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis" 22 : 845-854, 2013

      89 Ye M, "Exosomes derived from human induced pluripotent stem cells-endothelia cells promotes postnatal angiogenesis in mice bearing ischemic limbs" 15 : 158-168, 2019

      90 Lai RC, "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury" 4 : 214-222, 2010

      91 Lu M, "Enhanced wound healing promotion by immune response-free monkey autologous IPSCs and exosomes vs. their allogeneic counterparts" 42 : 443-457, 2019

      92 Wang K, "Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-21" 6 : 209-222, 2017

      93 Kobayashi H, "Effects of exosomes derived from the induced pluripotent stem cells on skin wound healing" 80 : 141-153, 2018

      94 Zhang Y, "Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury" 122 : 856-867, 2015

      95 Roskoski R, "ERK1/2 MAP kinases : structure, function, and regulation" 66 : 105-143, 2012

      96 Podvin S, "Dysregulation of exosome cargo by mutant tau expressed in human-induced pluripotent stem cell(IPSC)neurons revealed by proteomics analyses" 19 : 1017-1034, 2020

      97 Pardridge WM, "Drug transport across the blood-brain barrier" 32 : 1959-1972, 2012

      98 Archer CW, "Development of synovial joints" 69 : 144-155, 2003

      99 Jung Y, "Concise review : induced pluripotent stem cell-derived mesenchymal stem cells : progress toward safe clinical products" 30 : 42-47, 2012

      100 Phinney DG, "Concise review : MSC-derived exosomes for cell-free therapy" 35 : 851-858, 2017

      101 Sakaguchi Y, "Comparison of human stem cells derived from various mesenchymal tissues : superiority of synovium as a cell source" 52 : 2521-2529, 2005

      102 Zhu Y, "Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis" 8 : 64-, 2017

      103 Wang S, "Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects" 12 : 19546-19562, 2020

      104 Koh YG, "Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis" 23 : 1308-1316, 2015

      105 Mastrolia I, "Challenges in clinical development of mesenchymal stromal/stem cells : concise review" 8 : 1135-1148, 2019

      106 Wynn T, "Cellular and molecular mechanisms of fibrosis" 214 : 199-210, 2008

      107 Polo JM, "Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells" 28 : 848-855, 2010

      108 "Cardiovascular Diseases (CVDs)"

      109 Nakano M, "Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an alzheimer’s disease model by increasing the expression of MicroRNA-146a in hippocampus" 10 : 10772-, 2020

      110 Qin Y, "Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo" 6 : 21961-, 2016

      111 ter Huurne M, "Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis" 64 : 3604-3613, 2012

      112 Chiang ER, "Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits" 11 : e0149835-, 2016

      113 Sun Woo Lim ; Kyung Woon Kim ; Bo-Mi Kim ; 신유진 ; Kang Luo ; Yi Quan ; Sheng Cui ; Eun Jeong Ko ; Byung Ha Chung ; Chul Woo Yang, "Alleviation of renal ischemia/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells" 대한내과학회 37 (37): 411-424, 2022

      114 Zhang X, "Administration of mircorna-135b-reinforced exosomes derived from mscs ameliorates glucocorticoid-induced osteonecrosis of femoral head(ONFH)in rats" 24 (24): 13973-13983, 2020

      115 Lai P, "A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD" 11 : 135-, 2018

      116 Koyama E, "A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis" 316 : 62-73, 2008

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼